|
|
| 10/7/2008- | Biovest Announces BiovaxID® Anti-Cancer Vaccine Prolongs Cancer-Free Survival by 44%: -Company Closes Phase 3 Fast-Tracked Clinical Trial
-Will Petition to Offer All Study Patients Treatment with BiovaxID
-Intends to Seek Approval in the U.S. and Internationally
...
|
| 9/30/2008- | Torrey Pines Institute for Molecular Studies’ 103,000-Square-Foot Facility : Months ahead of schedule, the anchor tenant of the Florida Center for Innovation at Tradition (FCI) accepted its Certificate of Occupancy from Port St. Lucie officials today, making the Torrey Pines Institute for Molecular Studies (TPIMS) the first a ...
|
| 9/30/2008- | Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure : Bioheart, Inc., (Nasdaq:BHRT), today announced that 35 of the leading U.S. Heart Failure Centers have engaged in Bioheart’s Phase II/III MARVEL1 Trial of myogenic cells for treating advanced heart failure. ...
|
| 9/24/2008- | Planck sees operations starting in early 2009: The Max Planck Society hopes to hire a chief scientist for its Florida institute by November and have scientists working here early next year, a Society representative said Tuesday at a meeting of biotechnology firms. ...
|
| 9/23/2008- | Science Tunnel to make U.S. debut in S. Fla.: If you’ve ever wanted to ride a bicycle through Tubingen, Germany, at the speed of light, or fight a virus before it enters the body, the internationally renowned Science Tunnel is the place to be. ...
|
| 9/10/2008- | Altor BioScience Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital: Altor BioScience Corporation (Altor) today announced that it has entered into an agreement with Massachusetts General Hospital (MGH) for exclusive, worldwide rights to develop and commercialize T-cell receptors (TCRs) specific for cells infected by H ...
|
| 9/4/2008- | Banyan Biomarkers Announces U.S. Patent for Neural Proteins as Biomarkers for Traumatic Brain Injury : The U.S. Patent and Trademark Office has granted U.S. Patent No. 7,396,654 B2 "Neural Proteins as Biomarkers for Traumatic Brain Injury", licensed exclusively by Banyan Biomarkers from the University of Florida. ...
|
| 9/2/2008- | Spinoff to tap RNA's promise: Scripps Florida has launched a new spinoff company, its second.
Claes Wahlestedt, director of Central Nervous System drug discovery at Scripps Florida, has teamed up with Delray Beach angel investor Joe Collard to launch cuRNA, a firm that will try ...
|
| 9/2/2008- | Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008 : Washington, D.C. – More than 50 U.S. and international medical technology companies have been selected to present at AdvaMed 2008: The MedTech Conference. Company presentations offer a unique business development and information sharing opportunity f ...
|
| 8/18/2008- | Biz Monday: BioFlorida brings its bioscience voice, know-how to SW Fla.: The recent downturn in the Southwest Florida economy stands as proof that diversification beyond the traditional real-estate foundation is critical to our area's future. ...
|
| 8/11/2008- | AdvaMed 2008 Supporting Partner Organizations Up 30% Over Last Year: AdvaMed 2008: The MedTech Conference announced today participation of 37 Supporting Partner Organizations from around the world, including Australia, Canada, Ireland, Israel, New Zealand, Russia and the United Kingdom, as well as 30 state, regional a ...
|
| 8/4/2008- | Lott and Friedland Celebrates its 25th Year Anniversary: LOTT & FRIEDLAND, an intellectual property law firm based in Coral Gables, is celebrating its 25th year anniversary by hosting a cocktail reception at the Biltmore Hotel, in Coral Gables, on Tuesday, September 9, 2008. ...
|
| 7/25/2008- | Cancer therapies developed at UM spun off to new companies: Two potential cancer therapies developed at the University of Miami have been licensed to startup companies under the umbrella of a Miami Beach-based venture capital firm. ...
|
| 7/23/2008- | Pinellas finds $2-million to lure defense company: Pinellas County leaders pledged $2-million Tuesday to entice a prosperous Massachusetts company to the Tampa Bay area even as they expect a tax revenue crunch to force them to lay off workers. ...
|
| 7/22/2008- | Palm Beach County OKs $87 million for Max Planck: The Palm Beach County Commission today approved a plan to give the Max Planck Society of Germany almost $87 million to set up an institute near Scripps Florida in Jupiter.
Munich, Germany-based Max Planck will build a 100,000-square-foot bio-imagi ...
|
| 7/21/2008- | Med-school partnership solid: Re the July 14 story Hospital upends med-school plan: The University of Miami Miller School of Medicine at Florida Atlantic University would like to clarify a few points. The story implied that the future of the regional medical campus is in jeopardy ...
|
| 7/21/2008- | Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used in Successful Melanoma Trial : Plantation, FL, July 21, 2008 – Goodwin Biotechnology Inc. (GBI) today announced that the melanin-binding IgM antibody manufactured by the company was used in a successful Phase I clinical trial for the treatment of melanoma. The encouraging result ...
|
| 7/20/2008- | Class of antibiotics can enhance gene-silencing tool: A way to turn off one gene at a time has earned acceptance in biology laboratories over the last decade. Doctors envision the technique, called RNA interference, as a tool to treat a variety of diseases if it can be adapted to humans. ...
|
